phase readout
saveNCT03114462: Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal Cancer
RECRUITINGupdated 1mo ago
community read0 votes
Sponsor: M.D. Anderson Cancer Center. Phase: PHASE1. Conditions: Malignant Neoplasms of Respiratory and Intrathoracic Organs, Squamous Cell Carcinoma of the Larynx
view source ↗
comments(0)
5-min edit window · permanent after that